Radiofrequency Ablation Versus Reresection in Treating Recurrent Hepatocellular Carcinoma: A Meta-Analysis

Treatment for recurrent hepatocellular carcinoma (RHCC) remains controversial. This study tried to compare survival benefits between radiofrequency ablation (RFA) and reresection for RHCC patients following curative surgical treatments. Databases were searched for comparative studies published from...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Hao, Kong, Wentao, Zhou, Tie, Qiu, Yudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2014
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616312/
https://www.ncbi.nlm.nih.gov/pubmed/25396332
http://dx.doi.org/10.1097/MD.0000000000000122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616312/
https://www.ncbi.nlm.nih.gov/pubmed/25396332
http://dx.doi.org/10.1097/MD.0000000000000122

Ejemplares similares